Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2100 of 3173 entries
View as:

RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

Phase: N/A Priority: Normal
NCT ID: NCT04460898 Org: User:
Start: 01/04/19 End: 06/24/19 Due: 06/24/20

The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period.

Phase: N/A Priority: Normal
NCT ID: NCT01365637 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00567203 Org: User:
Start: 11/30/07 End: 05/31/08 Due: 05/31/09

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Phase: N/A Priority: Normal
NCT ID: NCT00052117 Org: User:
Start: 01/31/03 End: 05/31/05 Due: 05/31/06

Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02824094 Org: User:
Start: - End: - Due: -

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Phase: N/A Priority: Normal
NCT ID: NCT00038103 Org: User:
Start: 01/31/02 End: 03/31/08 Due: 03/31/09

Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00002076 Org: User:
Start: - End: - Due: -

20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT04379713 Org: User:
Start: 05/21/20 End: 08/31/22 Due: 08/31/23

Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone

Phase: N/A Priority: Normal
NCT ID: NCT05012644 Org: User:
Start: 07/16/21 End: 12/09/21 Due: 12/09/22

Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03114540 Org: User:
Start: 03/17/17 End: 03/22/18 Due: 03/22/19

Donepezil in the Prevention of Post-Operative Cognitive Decline

Phase: N/A Priority: Normal
NCT ID: NCT00182845 Org: User:
Start: 02/28/05 End: 04/30/07 Due: 04/30/08

Retrospective Analysis of Real World Use of Ceftazidime-avibactam in the Management of Gram Negative Infections

Phase: N/A Priority: Normal
NCT ID: NCT04628572 Org: User:
Start: 01/29/21 End: 03/11/22 Due: 03/11/23

Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height

Phase: N/A Priority: Normal
NCT ID: NCT00396474 Org: User:
Start: 01/31/09 End: 01/31/12 Due: 01/31/13

Tanezumab and Nerve Function In Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00863772 Org: User:
Start: 05/18/09 End: 11/16/10 Due: 11/16/11

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Phase: N/A Priority: Normal
NCT ID: NCT02319837 Org: User:
Start: 12/17/14 End: 09/19/26 Due: 09/19/27

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03416179 Org: User:
Start: 04/20/18 End: 01/17/22 Due: 01/17/23

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

Phase: N/A Priority: Normal
NCT ID: NCT00963235 Org: User:
Start: 11/30/09 End: 05/31/12 Due: 05/31/13

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01517373 Org: User:
Start: 02/29/12 End: 01/31/13 Due: 01/31/14

Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT02458287 Org: User:
Start: 06/30/15 End: 02/29/16 Due: 02/28/17

Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

Phase: N/A Priority: Normal
NCT ID: NCT05399459 Org: User:
Start: 08/09/22 End: 01/19/24 Due: 01/19/25

Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01056289 Org: User:
Start: 03/31/10 End: 02/28/11 Due: 02/28/12

Absolute Bioavailability Of Bosutinib

Phase: N/A Priority: Normal
NCT ID: NCT02192294 Org: User:
Start: 08/31/14 End: 10/31/14 Due: 10/31/15

A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT04253353 Org: User:
Start: 02/06/20 End: 08/10/20 Due: 08/10/21

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00002074 Org: User:
Start: - End: - Due: -

Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.

Phase: N/A Priority: Normal
NCT ID: NCT02709486 Org: User:
Start: 03/02/16 End: 11/14/18 Due: 11/14/19